Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, announced today that the Massachusetts Cannabis Control Commission (“CCC” or the “Commission”) has granted its local partner Sira Naturals (“Sira”) provisional licenses for the sale of adult-use cannabis at its Somerville and Watertown locations in Greater Boston and a provisional license for cultivation and production for its M3 cultivation facility, located in Milford, Massachusetts.
Both the Somerville location, where the Company currently operates a medical dispensary, and Watertown location, which is currently under construction, executed Host Community Agreements for the sale of adult-use cannabis in October 2020. Both dispensaries will serve medical patients and adult-use customers.
The Company’s M3 90,000 sq. ft. cultivation and production facility, currently being built, will triple Ayr’s cultivation capacity in the state. This will bring the Company to the maximum 100,000 sq. ft. of canopy allowed under its license and significantly increase its capacity to supply the Massachusetts wholesale market as well as internally source the expected increase in retail demand from its new adult-use locations.
Jonathan Sandelman, CEO of Ayr, said, “The Greater Boston Area has been drastically underserved in access to adult-use cannabis. The granting of our provisional adult-use licenses in Somerville and Watertown are a big step towards remedying that. Additionally, the buildout of our new cultivation facility in Milford is proceeding as planned. As we often state, our goal is to be the largest scale cultivator of high-quality cannabis in each and every market where we operate. The new facility will go a long way in helping us to achieve that goal and further our leading wholesale presence within the state.”
